Sandrine Faivre: Influence Statistics

Sandrine Faivre

Sandrine Faivre

Department of Medical Oncology Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Université de Paris, Paris, France. | Principal investigator

Sandrine Faivre: Expert Impact

Concepts for which Sandrine Faivre has direct influence: Metastatic colorectal cancer , Sirt patients , Sirt chemotherapy , Addition sirt , Metastatic colorectal , Selective internal , Internal radiation .

Sandrine Faivre: KOL impact

Concepts related to the work of other authors for which for which Sandrine Faivre has influence: Regional therapies , Colorectal liver metastases , Transarterial radioembolization , Microwave ablation , Radiomicrosphere therapy , Local treatments , Interventional oncology .

KOL Resume for Sandrine Faivre

Year
2022

Department of Medical Oncology Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Université de Paris, Paris, France.

2018

Principal investigator

Prominent publications by Sandrine Faivre

KOL-Index: 7558 . BACKGROUND: The primary tumor side is emerging as a major prognostic factor for patients with metastatic colorectal cancer (mCRC). We examined the survival data from 2 randomized studies to determine whether the outcomes differ between patients with mCRC with right-sided primary (RSP) tumors and those with left-sided primary (LSP) tumors after selective internal radiation therapy (SIRT) ...
Known for Metastatic Colorectal Cancer | Survival Outcomes | Primary Tumor | Sirt Patients

Key People For Metastatic Colorectal Cancer

Top KOLs in the world
#1
Eric Van Van Cutsem
colorectal cancer advisory consultancy grant funding institution
#2
David C Cunningham
colorectal cancer consultancy funding board directors
#3
Philippe Rougier
colorectal cancer liver metastases adjuvant chemotherapy
#4
Josep M Tabernero
colorectal cancer advanced solid tumors monoclonal antibodies
#5
Salvatore Siena
colorectal cancer solid tumors monoclonal antibodies
#6
DANIEL J SARGENT
colon cancer phase iii adjuvant chemotherapy

Department of Medical Oncology Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Université de Paris, Paris, France. | Principal investigator